AbbVie Inc., US00287Y1091

AbbVie Inc. stock rises 0.7 percent ahead of the open

Published on 09/22/2026 at 08:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 21, 2026, AbbVie Inc. stock reached USD 265.75 after trading between USD 263.14 and USD 266.50. The S&P 500 gained 1.49 percent to 7,764.70 points.

Fotorealistisches Pharma-Forschungslabor mit Petrischalen und Wissenschaftlern in Schutzkleidung
AbbVie Inc. US00287Y1091 fotorealistisches Pharma Forschungslabor mit Petrischalen Wissenschaftlern Immunologie Onkologie Biopharma, Illustration mit AI erstellt.

AbbVie Inc. stock closed at USD 265.75 on the NYSE on September 21, 2026, up 0.7 percent. The shares outperformed the S&P 500 session gain of 1.49 percent only in absolute terms relative to their prior close, while the index ended at 7,764.70 points.

September 21, 2026 in numbers

AbbVie Inc. (ISIN US00287Y1091, NYSE: ABBV) opened at USD 263.14 and reached a session high of USD 266.50, according to dated market data. Trading volume was reported at 183,244 shares during the session snapshot. The stock remained USD 1.72 below its reported 52-week high of USD 267.47.

As Yahoo Finance reported on September 21, 2026, AbbVie and Iambic announced a multi-year collaboration on AI-driven drug discovery across immunology, neuroscience and oncology.

AbbVie event on September 22, 2026

AbbVie is scheduled to participate in a pre-conference event on September 22, 2026, according to NBMBAA. The companys next quarterly results are reported as due on October 23, 2026, according to Finanzen.ch.

Disclaimer...

en | US00287Y1091 | ABBVIE INC. | boerse | 70151927 | bgmi